Five clinics will be participating in a Phase 3 Double Blind placebo controlled study for the treatment of Diabetic Neuropathy. Qualified participants will spend 8 - 10 hours a day for 12 to 15 consecutive days, for which they will be paid. Follow up evaluations immediately following and for 6 months after the procedure will be required.
Update: We are no longer accepting study participants for this study.
|
